Cleared Traditional

K905445 - ADSON-BECKMAN RETRACTOR, SPINAL

K905445 is an FDA 510(k) clearance for ADSON-BECKMAN RETRACTOR, manufactured by A. Henniss. The device is a Class 2 Neurology device with product code GZT cleared through the Traditional 510(k) pathway after a 52-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1991
Decision
52d
Days
Class 2
Risk

K905445 is an FDA 510(k) clearance for the ADSON-BECKMAN RETRACTOR, SPINAL. Classified as Retractor, Self-retaining, For Neurosurgery (product code GZT), Class II - Special Controls.

Submitted by A. Henniss (Tarzana, US). The FDA issued a Cleared decision on January 25, 1991 after a review of 52 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4800 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K905445

510(k) Number K905445 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 04, 1990
Decision Date January 25, 1991
Days to Decision 52 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 149d · This submission: 52d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZT Device Classification - Class 2, Special Controls

Product Code GZT Retractor, Self-retaining, For Neurosurgery
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZT Retractor, Self-retaining, For Neurosurgery

All 43
Devices cleared under the same product code (GZT) and FDA review panel - the closest regulatory comparables to K905445.
TENS DEVICE FOR RELIEF OF CHRONIC PAIN, MODIFIED
K924876 · Graham-Field, Inc. · Mar 1994
CODMAN LHALO SPLIT RING RETRACTOR SYSTEM
K913233 · Codman & Shurtleff, Inc. · Jul 1991
BLADES FOR SPINAL LAMINECTOMY RETRACTOR
K910621 · International Hospital Supply Co. · Apr 1991
NEUROSURGICAL HEADFRAME ACCESSORIES
K902517 · Sims Surgical, Inc. · Jul 1990
ESI MODEL MS-103
K885120 · Electrical Systems Div. · Jan 1990
COMPASS(TM) STEREOTACTIC RETRACTOR SYSTEM
K896156 · Stereotactic Medical Systems, Inc. · Dec 1989